DS
DSP Multi Cap Fund Direct Growth
Latest NAV
-1.41% 1Y
Sign In to Add to Portfolio
Benchmark: NIFTY500 Multicap 50:25:25 Total Return Index
Expense ratio
0.70%
AUM
₹3,025 Cr
Min SIP
₹100
Min lump sum
₹100
1Y
-1.41%
3Y (ann.)
+0.00%
5Y (ann.)
+0.00%
Launched
Jan 2024
Where the NAV sits & how risky it is
₹12.25
52-week range
at 67%
₹12.25
Low 30 Mar 2026₹10.71
High 26 Aug 2026₹13.00
Risk level
Very High
Low
Very high
NAV history
31 Jan 2024
Since inception
05 Oct 2026
Returns by period
1W
-2.16%
1M
-5.18%
3M
-3.09%
6M
+12.17%
1Y
-1.41%
3Y
+0.00%
5Y
+0.00%
3Y and 5Y returns are annualised.
Return calculator
You invest
—
Est. gain
—
Est. value
—
Invested Gain
Invested
Projected value
min SIP ₹100
Estimate only. It assumes the selected past return repeats every year; 3Y and 5Y figures are taken as annualised. Actual returns vary and are not guaranteed.
Where your money goes
AS OF 31 MAY 2026
Equity 91.89%
Cash & other 8.11%
Sector split
Country split
Top 5 hold 18.3%
Top 10 hold 30.4%
64 equity holdings
Equity holdings
(top 30)
| # | Holding | Sector | Country | Weight | YTD |
|---|---|---|---|---|---|
| 1 | HDFC Bank
INE040A01034 |
Financial Services Banks - Regional |
India |
4.96%
|
-24.88% |
| 2 | Axis Bank
INE238A01034 |
Financial Services Banks - Regional |
India |
4.06%
|
+3.77% |
| 3 | ICICI Bank
INE090A01021 |
Financial Services Banks - Regional |
India |
3.83%
|
-1.93% |
| 4 | ICICI Lombard General Insurance
INE765G01017 |
Financial Services Insurance - Diversified |
India |
2.80%
|
-11.36% |
| 5 | Max Financial Services
INE180A01020 |
Financial Services Insurance - Life |
India |
2.60%
|
-4.40% |
| 6 | Hero Motocorp
INE158A01026 |
Consumer Cyclical Auto Manufacturers |
India |
2.51%
|
-13.94% |
| 7 | Kirloskar Oil Engines
INE146L01010 |
Industrials Specialty Industrial Machinery |
India |
2.43%
|
+49.61% |
| 8 | Coforge
INE591G01025 |
Technology Information Technology Services |
India |
2.39%
|
-15.41% |
| 9 | KEI Industries
INE878B01027 |
Industrials Electrical Equipment & Parts |
India |
2.39%
|
+16.27% |
| 10 | Cipla
INE059A01026 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
2.38%
|
-8.03% |
About this scheme
The investment objective of the scheme is to seek to generate long-term capital appreciation from a portfolio of equity and equity related securities across market capitalization. There is no assurance that the investment objective of the Scheme will be achieved.
Fund manager(s): Chirag Dagli
Exit load: Exit load of 1%, if redeemed within 12 months.
Scheme snapshot
VR Rating
MS Rating
Plan
Growth
Type
DIRECT
Inception
30 Jan 2024
Lump-sum min
₹100
SIP
Purchase
Switch
STP
SWP
Similar schemes
RANKED BY 1Y RETURN
Nippon India Taiwan Equity Fund Direct Growth
1▲ 123.0 pts ahead of this fund
Franklin Asian Equity Fund Direct Growth
2▲ 34.8 pts ahead of this fund
Nippon India Japan Equity Fund - Direct Plan - Growth Plan - Bonus Option
3▲ 32.0 pts ahead of this fund
Nippon India Japan Equity Fund Direct Growth
4▲ 32.0 pts ahead of this fund
Bank of India Small Cap Fund Direct Growth
5▲ 30.7 pts ahead of this fund
TRUSTMF Small Cap Fund Direct Growth
6▲ 30.5 pts ahead of this fund